Concord Drugs Limited (CONCORD.BO)
INR 29.95
(0.0%)
INR 29.95
(0.0%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 116.7 Million INR | 5.6% |
| 2022 | 110.51 Million INR | -34.3% |
| 2021 | 168.2 Million INR | 103.01% |
| 2020 | 82.85 Million INR | -4.07% |
| 2019 | 86.36 Million INR | 5.65% |
| 2018 | 81.74 Million INR | -2.61% |
| 2017 | 83.93 Million INR | -25.14% |
| 2016 | 112.12 Million INR | -5.31% |
| 2015 | 118.4 Million INR | 31.97% |
| 2014 | 89.72 Million INR | 95.29% |
| 2013 | 45.94 Million INR | 35.6% |
| 2012 | 33.88 Million INR | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 26.71 Million INR | 11.8% |
| 2023 FY | 116.7 Million INR | 5.6% |
| 2023 Q4 | 23.89 Million INR | -10.26% |
| 2023 Q3 | 26.62 Million INR | -22.26% |
| 2023 Q2 | 34.25 Million INR | 7.29% |
| 2023 Q1 | 31.92 Million INR | 113.09% |
| 2022 Q4 | 14.98 Million INR | -60.76% |
| 2022 FY | 110.51 Million INR | -34.3% |
| 2022 Q3 | 38.18 Million INR | 28.55% |
| 2022 Q2 | 29.7 Million INR | 7.45% |
| 2022 Q1 | 27.64 Million INR | -58.76% |
| 2021 Q1 | 43.69 Million INR | 90.76% |
| 2021 Q2 | 31.22 Million INR | -28.55% |
| 2021 Q4 | 67.02 Million INR | 155.28% |
| 2021 Q3 | 26.25 Million INR | -15.9% |
| 2021 FY | 168.2 Million INR | 103.01% |
| 2020 Q4 | 22.9 Million INR | 10.67% |
| 2020 FY | 82.85 Million INR | -4.07% |
| 2020 Q3 | 20.69 Million INR | -15.71% |
| 2020 Q1 | 22.6 Million INR | 15.79% |
| 2020 Q2 | 24.55 Million INR | 8.64% |
| 2019 FY | 86.36 Million INR | 5.65% |
| 2019 Q2 | 23.9 Million INR | 11.24% |
| 2019 Q4 | 19.52 Million INR | -9.46% |
| 2019 Q3 | 21.56 Million INR | -9.8% |
| 2019 Q1 | 21.48 Million INR | 53.15% |
| 2018 Q2 | 22.34 Million INR | 6.5% |
| 2018 FY | 81.74 Million INR | -2.61% |
| 2018 Q4 | 14.03 Million INR | -48.57% |
| 2018 Q1 | 20.98 Million INR | 933.09% |
| 2018 Q3 | 27.27 Million INR | 22.08% |
| 2017 Q1 | 21.95 Million INR | 73.06% |
| 2017 FY | 83.93 Million INR | -25.14% |
| 2017 Q4 | -2.51 Million INR | -106.64% |
| 2017 Q3 | 37.9 Million INR | 48.74% |
| 2017 Q2 | 25.48 Million INR | 16.04% |
| 2016 Q1 | 25.37 Million INR | -14.31% |
| 2016 FY | 112.12 Million INR | -5.31% |
| 2016 Q3 | 46.77 Million INR | 61.25% |
| 2016 Q4 | 12.68 Million INR | -72.87% |
| 2016 Q2 | 29 Million INR | 14.31% |
| 2015 Q4 | 29.61 Million INR | -42.81% |
| 2015 Q2 | 22.13 Million INR | 59.56% |
| 2015 Q1 | 13.87 Million INR | 353.61% |
| 2015 FY | 118.4 Million INR | 31.97% |
| 2015 Q3 | 51.77 Million INR | 133.94% |
| 2014 Q1 | 21.23 Million INR | 14.81% |
| 2014 FY | 89.72 Million INR | 95.29% |
| 2014 Q4 | 3.05 Million INR | -84.12% |
| 2014 Q3 | 19.25 Million INR | -12.16% |
| 2014 Q2 | 21.91 Million INR | 3.21% |
| 2013 Q3 | 12.23 Million INR | 8.62% |
| 2013 Q2 | 11.25 Million INR | 9.68% |
| 2013 Q4 | 18.49 Million INR | 51.23% |
| 2013 FY | 45.94 Million INR | 35.6% |
| 2013 Q1 | 10.26 Million INR | 71.12% |
| 2012 FY | 33.88 Million INR | 0.0% |
| 2012 Q4 | 5.99 Million INR | -38.26% |
| 2012 Q3 | 9.71 Million INR | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 3.14 Million INR | -3616.401% |
| Sastasundar Ventures Limited | 1.19 Billion INR | 90.271% |
| KIMIA BIOSCIENCES LIMITED | 111.76 Million INR | -4.42% |
| SHELTER PHARMA LIMITED | 110.97 Million INR | -5.166% |
| Vasundhara Rasayans Limited | 207.68 Million INR | 43.807% |
| Sunil Healthcare Limited | 247.86 Million INR | 52.916% |
| Chemo Pharma Laboratories Limited | 18.38 Million INR | -534.882% |
| MedPlus Health Services Limited | 12.33 Billion INR | 99.054% |
| Zenith Healthcare Limited | 46.17 Million INR | -152.748% |
| Patidar Buildcon Limited | -26 Thousand INR | 448961.538% |
| Sanjivani Paranteral Limited. | 208.87 Million INR | 44.128% |
| Roopa Industries Limited | 72.95 Million INR | -59.971% |
| Smruthi Organics Limited | 324.76 Million INR | 64.065% |
| Trident Lifeline Limited | 119.08 Million INR | 1.997% |
| Bacil Pharma Limited | -19.95 Thousand INR | 585082.456% |
| Pharmaids Pharmaceuticals Limited | -72.81 Million INR | 260.268% |
| Gujarat Terce Laboratories Limited | 141.4 Million INR | 17.471% |
| Bharat Immunologicals & Biologicals Corporation Limited | -146.67 Million INR | 179.566% |
| Sandu Pharmaceuticals Limited | 347.1 Million INR | 66.378% |
| PANJON LTD. | 33.77 Million INR | -245.493% |
| Tyche Industries Limited | 290.84 Million INR | 59.874% |
| Trimurthi Limited | 1.95 Million INR | -5881.753% |
| TIAAN CONSUMER LIMITED | -17.81 Million INR | 755.272% |
| Anuh Pharma Limited | 1.6 Billion INR | 92.722% |
| Crestchem Limited | 51.53 Million INR | -126.444% |
| Emmessar Biotech & Nutrition Limited | -7.43 Million INR | 1670.079% |
| Zenlabs Ethica Limited | 147.75 Million INR | 21.015% |
| Vikram Thermo (India) Limited | 443.73 Million INR | 73.7% |
| ANG Lifesciences India Limited | 232.73 Million INR | 49.855% |
| Parmax Pharma Limited | 99.31 Million INR | -17.506% |
| Fredun Pharmaceuticals Limited | 724.71 Million INR | 83.897% |
| Deccan Health Care Limited | 221.57 Million INR | 47.329% |
| Shukra Pharmaceuticals Limited | 300.38 Million INR | 61.149% |
| Norris Medicines Limited | 29.36 Million INR | -297.462% |
| SUDARSHAN PHARMA INDUSTRIES LI | 361.76 Million INR | 67.741% |
| Veerhealth Care Limited | 49.57 Million INR | -135.414% |
| Makers Laboratories Limited | 308.54 Million INR | 62.176% |
| Lactose (India) Limited | 230.3 Million INR | 49.327% |
| OXYGENTA PHARMACEUTICAL LIMITE | -99.79 Million INR | 216.947% |
| Ambalal Sarabhai Enterprises Limited | 717.63 Million INR | 83.738% |
| Mercury Laboratories Limited | 279.39 Million INR | 58.229% |
| Gennex Laboratories Limited | 276.99 Million INR | 57.868% |
| PRAVEG LIMITED | 266.99 Million INR | 56.29% |
| Denis Chem Lab Limited | 596.24 Million INR | 80.427% |
| Kwality Pharmaceuticals Limited | 1.43 Billion INR | 91.879% |
| Jenburkt Pharmaceuticals Limited | 1.1 Billion INR | 89.47% |
| Colinz Laboratories Limited | 16.35 Million INR | -613.568% |
| Godavari Drugs Limited | 359.01 Million INR | 67.493% |
| SHAMROCK INDUSTRIAL CO.LTD. | -406 Thousand INR | 28844.828% |
| Zenotech Laboratories Limited | 337.19 Million INR | 65.39% |
| Panchsheel Organics Limited | 356.44 Million INR | 67.259% |
| Shree Ganesh Remedies Limited | 674.17 Million INR | 82.689% |
| Vivanza Biosciences Limited | 19.38 Million INR | -501.97% |
| Phaarmasia Limited | 38.89 Million INR | -200.087% |
| Bharat Parenterals Limited | 989.46 Million INR | 88.205% |
| Medi-Caps Limited | 68.09 Million INR | -71.392% |
| DECIPHER LABS LIMITED | 331.34 Million INR | 64.778% |
| Gujarat Themis Biosyn Limited | 1.28 Billion INR | 90.898% |
| BDH Industries Limited | 175.55 Million INR | 33.523% |
| Vista Pharmaceuticals Limited | 10.02 Million INR | -1064.711% |
| Coral Laboratories Limited | 332.39 Million INR | 64.89% |
| Beryl Drugs Limited | 108.5 Million INR | -7.558% |
| Evoq Remedies Limited | 47.43 Million INR | -146.034% |
| Add-Shop E-Retail Limited | 224.09 Million INR | 47.923% |
| Transchem Limited | -8.96 Million INR | 1401.628% |
| Ishita Drugs and Industries Limited | 38.94 Million INR | -199.694% |
| Parnax Lab Limited | 552.1 Million INR | 78.862% |
| Source Natural Foods and Herbal Supplements Limited | 66.01 Million INR | -76.792% |
| Kerala Ayurveda Limited | 447.69 Million INR | 73.932% |
| Cian Healthcare Limited | 113.16 Million INR | -3.125% |
| Trinity League India Limited | 1.23 Million INR | -9372.727% |
| Syschem (India) Limited | 569.04 Million INR | 79.491% |
| KOBO BIOTECH LIMITED | -40.71 Million INR | 386.643% |
| Natural Capsules Limited | 557.1 Million INR | 79.052% |
| Auro Laboratories Limited | 249.39 Million INR | 53.204% |